Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2011, Article ID 748745, 8 pages
http://dx.doi.org/10.1155/2011/748745
Review Article

Lymph Node Dissection in Curative Gastrectomy for Advanced Gastric Cancer

Department of Surgery, Kansai Rosai Hospital, 1-69 3-Chome, Inabasou, Amagasaki, Hyogo 660-8511, Japan

Received 15 January 2011; Accepted 29 March 2011

Academic Editor: Michael Hünerbein

Copyright © 2011 Shigeyuki Tamura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Pisani, D. M. Parkin, F. Bray, and J. Ferlay, “Estimates of the worldwide mortality from 25 cancers in 1990,” International Journal of Cancer, vol. 83, no. 1, pp. 18–29, 1999. View at Google Scholar · View at Scopus
  2. F. Lordick and J. R. Siewert, “Perioperative chemotherapy vs. surgery alone in resectable gastroesophsageal carcinoma,” Results of the MAGIC Study. Chirun, vol. 77, pp. 1166–1167, 2006. View at Google Scholar
  3. J. S. Macdonald, S. R. Smalley, J. Benedetti et al., “Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction,” The New England Journal of Medicine, vol. 345, no. 10, pp. 725–730, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. T. Kajitani, “The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification,” Japanese Journal of Surgery, vol. 11, no. 2, pp. 127–139, 1981. View at Google Scholar · View at Scopus
  5. J. Bonenkamp, I. Songun, J. Hermans et al., “Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients,” The Lancet, vol. 345, no. 8952, pp. 745–748, 1995. View at Publisher · View at Google Scholar
  6. A. Cuschieri, P. Fayers, J. Fielding et al., “Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial,” The Lancet, vol. 347, no. 9007, pp. 995–999, 1996. View at Publisher · View at Google Scholar
  7. R. Biffi, A. Chiappa, F. Luca et al., “Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients,” Journal of Surgical Oncology, vol. 93, no. 5, pp. 394–400, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. F. Roviello, D. Marrelli, P. Morgagni et al., “Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study,” Annals of Surgical Oncology, vol. 9, no. 9, pp. 894–900, 2002. View at Google Scholar
  9. M. Degiuli, M. Sasako, A. Ponti, T. Soldati, F. Danese, and F. Calvo, “Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian gastric cancer study group prospective multicenter surgical study,” Journal of Clinical Oncology, vol. 16, no. 4, pp. 1490–1493, 1998. View at Google Scholar
  10. M. Degiuli, M. Sasako, M. Calgaro et al., “Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial,” European Journal of Surgical Oncology, vol. 30, no. 3, pp. 303–308, 2004. View at Publisher · View at Google Scholar · View at PubMed
  11. Japanese Gastric Cancer Association, “Japanese classification of gastric carcinoma—2nd English edition,” Gastric Cancer, vol. 1, pp. 10–24, 1998. View at Google Scholar
  12. Japanese Gastric Cancer Association, Japanese Classification of Gastric Cancer, Kanehara & Co. Ltd, Tokyo, Japan, 14th edition, 2010.
  13. K. Maruyama, M. Sasako, T. Kinoshita et al., “Should systematic lymph node dissection be recommended for gastric cancer?” European Journal of Cancer, vol. 34, no. 10, pp. 1480–1489, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. Japanese Gastric Cancer Association, Gastric Cancer Treatment Guidelines, Kanehara & Co. Ltd, Tokyo, Japan, 2010.
  15. F. L. Greene, D. L. Page, and I. D. Fleming, Eds., AJCC Cancer Staging Manual: TNM Classification of Malignant Tumors, Springer, New York, NY, USA, 6th edition, 2002.
  16. S. B. Edge, D. R. Byrd, C. C. Compton, A. G. Fritz, F. L. Greene, and A. Trotti, AJCC Cancer Staging Handbook, Springer, New York, NY, USA, 7th edition, 2010.
  17. H. H. Hartgritik, C. J. H. van de Velde, H. Putter et al., “Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial,” Journal of Clinical Oncology, vol. 22, no. 11, pp. 2069–2077, 2004. View at Publisher · View at Google Scholar · View at PubMed
  18. A. M. G. Bunt, J. Hermans, M. C. Boon et al., “Evaluation of the extent of lymphadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer,” Journal of Clinical Oncology, vol. 12, no. 2, pp. 417–422, 1994. View at Google Scholar · View at Scopus
  19. I. Songun, H. Putter, E. M. K. Kranenbarg, M. Sasako, and C. J. H. van de Velde, “Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial,” The Lancet Oncology, vol. 11, no. 5, pp. 439–449, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Cuschieri, S. Weeden, J. Fielding et al., “Patient survival after D1 and D2 dissections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group,” British Journal of Cancer, vol. 79, pp. 1522–1530, 1999. View at Google Scholar
  21. C. W. Wu, C. A. Hsiung, S. S. Lo et al., “Nodal dissection for patients with gastric cancer: a randomised controlled trial,” The Lancet Oncology, vol. 7, no. 4, pp. 309–315, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. C. W. Wu, C. A. Hsiung, S. S. Lo, M. C. Hsieh, L. T. Shia, and J. Whang-Peng, “Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer,” British Journal of Surgery, vol. 91, no. 3, pp. 283–287, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. H. Isozaki, K. Okajima, K. Fujii et al., “Effectiveness of paraaortic lymph node dissection for advanced gastric cancer,” Hepato-Gastroenterology, vol. 46, no. 25, pp. 549–554, 1999. View at Google Scholar
  24. M. Baba, S. Hokita, S. Natsugoe et al., “Paraaortic lymphadenectomy in patients with advanced carcinoma of the upper-third of the stomach,” Hepato-Gastroenterology, vol. 47, no. 33, pp. 893–896, 2000. View at Google Scholar · View at Scopus
  25. C. Kunisaki, H. Shimada, H. Yamaoka et al., “Indications for paraaortic lymph node dissection in gastric cancer patients with paraaortic lymph node involvement,” Hepato-Gastroenterology, vol. 47, no. 32, pp. 586–589, 2000. View at Google Scholar · View at Scopus
  26. S. Takashima and T. Kosaka, “Results and controversial issues regarding a para-aortic lymph node dissection for advanced gastric cancer,” Surgery Today, vol. 35, no. 6, pp. 425–431, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. M. Sasako, T. Sano, S. Yamamoto et al., “D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer,” The The New England Journal of Medicine, vol. 359, no. 5, pp. 453–462, 2008. View at Publisher · View at Google Scholar · View at PubMed
  28. X. Z. Chen, J. K. Hu, Z. G. Zhou et al., “Meta-analysis of effectiveness and safety of D2 plus para-aortic lymphadenectomy for resectable gastric cancer,” Journal of the American College of Surgeons, vol. 210, no. 1, pp. 100–105, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. J. Kulig, T. Popiela, P. Kolodziejczyk, M. Sierzega, and A. Szczepanik, “Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial,” American Journal of Surgery, vol. 193, no. 1, pp. 10–15, 2007. View at Publisher · View at Google Scholar · View at PubMed
  30. Y. Yonemura, C. C. Wu, N. Fukushima et al., “Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons,” Hepato-Gastroenterology, vol. 53, no. 69, pp. 389–394, 2006. View at Google Scholar
  31. Y. Yonemura, C. C. Wu, N. Fukushima et al., “East Asia Surgical Oncology Group. Randomized clinical trial of D2 and extended paraaaortic lymph adenectomy in patients with gastric cancer,” International Journal of Clinical Oncology, vol. 13, pp. 132–137, 2008. View at Google Scholar
  32. Z. Wang, J. Q. Chen, and Y. F. Cao, “Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer,” World Journal of Gastroenterology, vol. 16, no. 9, pp. 1138–1149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Koufuji, K. Shirouzu, K. Aoyagi et al., “Surgery and clinicopathological features of gastric adenocarcinoma involving the esophago-gastric junction,” Kurume Medical Journal, vol. 52, no. 3, pp. 73–79, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Sasako, T. Sano, S. Yamamoto et al., “Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial,” Lancet Oncology, vol. 7, no. 8, pp. 644–651, 2006. View at Publisher · View at Google Scholar · View at PubMed
  35. K. Okajima and H. Isozaki, “Splenectomy for treatment of gastric cancer: Japanese experience,” World Journal of Surgery, vol. 19, no. 4, pp. 537–540, 1995. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Noguchi, T. Imada, A. Matsumoto, D. G. Coit, and M. F. Brennan, “Radical surgery for gastric cancer. A review of the Japanese experience,” Cancer, vol. 64, no. 10, pp. 2053–2062, 1989. View at Google Scholar · View at Scopus
  37. K. Kitamura, S. Nishida, D. Ichikawa et al., “No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer,” British Journal of Surgery, vol. 86, no. 1, pp. 119–122, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. Y. Kodera, Y. Yamamura, Y. Shimizu et al., “Lack of benefit of combined pancreaticosplenectomy in D2 resection for proximal-third gastric carcinoma,” World Journal of Surgery, vol. 21, no. 6, pp. 622–628, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Maruyama, M. Sasako, T. Kinoshita, T. Sano, H. Katai, and K. Okajima, “Pancreas-preserving total gastrectomy for proximal gastric cancer,” World Journal of Surgery, vol. 19, no. 4, pp. 532–536, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Furukawa, M. Hiratsuka, O. Ishikawa et al., “Total gastrectomy with dissection of lymph nodes along the splenic artery: a pancreas-preserving method,” Annals of Surgical Oncology, vol. 7, no. 9, pp. 669–673, 2000. View at Google Scholar · View at Scopus
  41. T. Sano, M. Sasako, S. Yamamoto et al., “Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group study 9501,” Journal of Clinical Oncology, vol. 22, no. 14, pp. 2767–2773, 2004. View at Publisher · View at Google Scholar · View at PubMed
  42. P. A. Clavien, M. G. Sarr, and Y. Fong, “Atlas of upper gastrointestinal and hepato-pancreatico-biliary surger,” in Total Gastrectomy with Radical Systemic Lymphadenectomy, M. Sasako, Ed., pp. 179–188, Springer, New York, NY, USA, 2007. View at Google Scholar
  43. K. Yoshino, Y. Yamada, F. Asanuma, and K. Aizawa, “Splenectomy in cancer gastrectomy: recommendation of spleen-preserving for early stages,” International Surgery, vol. 82, no. 2, pp. 150–154, 1997. View at Google Scholar · View at Scopus
  44. M. Ikeguchi and N. Kaibara, “Lymph node metastasis at the splenic hilum in proximal gastric cancer,” American Surgeon, vol. 70, no. 7, pp. 645–648, 2004. View at Google Scholar · View at Scopus
  45. A. Csendes, P. Burdiles, J. Rojas, I. Braghetto, J. C. Diaz, and F. Maluenda, “A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma,” Surgery, vol. 131, no. 4, pp. 401–407, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. W. Yu, G. S. Choi, and H. Y. Chung, “Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer,” British Journal of Surgery, vol. 93, no. 5, pp. 559–563, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. D. Cunningham, W. H. Allum, S. P. Stenning et al., “Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer,” The New England Journal of Medicine, vol. 355, no. 1, pp. 11–20, 2006. View at Publisher · View at Google Scholar · View at PubMed
  48. S. Sakuramoto, M. Sasako, T. Yamaguchi et al., “Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine,” The New England Journal of Medicine, vol. 357, no. 18, pp. 1810–1820, 2007. View at Publisher · View at Google Scholar · View at PubMed
  49. X. Paoletti, K. Oba, T. Burzykowski et al., “Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis,” JAMA—Journal of the American Medical Association, vol. 303, no. 17, pp. 1729–1737, 2010. View at Publisher · View at Google Scholar · View at PubMed
  50. Y. J. Bang, E. Van Cutsem, A. Feyereislova et al., “Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial,” The Lancet, vol. 376, no. 9742, pp. 687–697, 2010. View at Publisher · View at Google Scholar